$ICAD
ICAD INC

2022 Q4 Form 10-Q Financial Statement

#000119312522283502 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $6.489M $6.356M $9.361M
YoY Change -16.89% -32.1% 31.29%
Cost Of Revenue $1.853M $1.983M $2.649M
YoY Change -11.93% -25.14% 26.14%
Gross Profit $4.636M $4.373M $6.712M
YoY Change -18.72% -34.85% 33.44%
Gross Profit Margin 71.44% 68.8% 71.7%
Selling, General & Admin $6.112M $6.140M $6.544M
YoY Change -16.74% -6.17% 36.05%
% of Gross Profit 131.84% 140.41% 97.5%
Research & Development $1.813M $2.137M $2.285M
YoY Change -25.97% -6.48% 23.51%
% of Gross Profit 39.11% 48.87% 34.04%
Depreciation & Amortization $117.0K $130.0K $146.0K
YoY Change -15.83% -10.96% -2.67%
% of Gross Profit 2.52% 2.97% 2.18%
Operating Expenses $7.969M $8.333M $8.893M
YoY Change -19.11% -6.3% 32.34%
Operating Profit -$3.333M -$3.960M -$2.181M
YoY Change -19.65% 81.57% 29.05%
Interest Expense $122.0K $7.000K $5.000K
YoY Change 3966.67% 40.0% -104.55%
% of Operating Profit
Other Income/Expense, Net $0.00 $62.00K $5.000K
YoY Change 1140.0%
Pretax Income -$3.211M -$3.898M -$2.176M
YoY Change -22.53% 79.14% 21.56%
Income Tax -$116.0K $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.095M -$3.898M -$2.176M
YoY Change -25.35% 79.14% 20.89%
Net Earnings / Revenue -47.7% -61.33% -23.25%
Basic Earnings Per Share -$0.15 -$0.09
Diluted Earnings Per Share -$0.12 -$0.15 -$86.86K
COMMON SHARES
Basic Shares Outstanding 25.45M 25.33M 25.05M
Diluted Shares Outstanding 25.20M 25.05M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.31M $24.59M $35.81M
YoY Change -37.83% -31.32% 58.22%
Cash & Equivalents $21.31M $24.59M $35.81M
Short-Term Investments
Other Short-Term Assets $2.641M $2.203M $1.331M
YoY Change 147.52% 65.51% -19.82%
Inventory $5.389M $5.630M $3.290M
Prepaid Expenses
Receivables $8.898M $8.472M $12.45M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $38.24M $42.48M $52.88M
YoY Change -23.98% -19.66% 47.62%
LONG-TERM ASSETS
Property, Plant & Equipment $1.074M $986.0K $2.101M
YoY Change 21.77% -53.07% -18.25%
Goodwill $8.362M $8.362M
YoY Change 0.0%
Intangibles $482.0K $535.0K
YoY Change -29.43%
Long-Term Investments
YoY Change
Other Assets $12.39M $67.00K $55.00K
YoY Change 22427.27% 21.82% -45.0%
Total Long-Term Assets $13.46M $12.90M $12.86M
YoY Change 13.29% 0.26% 7.26%
TOTAL ASSETS
Total Short-Term Assets $38.24M $42.48M $52.88M
Total Long-Term Assets $13.46M $12.90M $12.86M
Total Assets $51.71M $55.37M $65.74M
YoY Change -16.86% -15.76% 37.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.973M $2.423M $2.651M
YoY Change -29.0% -8.6% 27.45%
Accrued Expenses $4.681M $5.544M $6.379M
YoY Change -17.03% -13.09% 15.98%
Deferred Revenue $6.216M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.45M $14.60M $14.96M
YoY Change -10.09% -2.4% 5.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $3.345M $3.111M $951.0K
YoY Change 373.13% 227.13% -37.02%
Total Long-Term Liabilities $3.345M $3.111M $951.0K
YoY Change 373.13% 227.13% -88.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.45M $14.60M $14.96M
Total Long-Term Liabilities $3.345M $3.111M $951.0K
Total Liabilities $16.80M $17.72M $15.92M
YoY Change 7.2% 11.31% -29.14%
SHAREHOLDERS EQUITY
Retained Earnings -$266.8M -$263.7M
YoY Change 5.39%
Common Stock $303.2M $302.8M
YoY Change 0.68%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.415M $1.415M
YoY Change 0.0%
Treasury Stock Shares $185.8K $185.8K
Shareholders Equity $34.90M $37.66M $49.82M
YoY Change
Total Liabilities & Shareholders Equity $51.71M $55.37M $65.74M
YoY Change -16.86% -15.76% 37.5%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$3.095M -$3.898M -$2.176M
YoY Change -25.35% 79.14% 20.89%
Depreciation, Depletion And Amortization $117.0K $130.0K $146.0K
YoY Change -15.83% -10.96% -2.67%
Cash From Operating Activities -$3.129M -$2.651M -$2.284M
YoY Change 102.26% 16.07% -9.0%
INVESTING ACTIVITIES
Capital Expenditures $169.0K -$100.0K -$114.0K
YoY Change -223.36% -12.28% 14.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$169.0K -$100.0K -$114.0K
YoY Change 23.36% -12.28% 14.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $373.0K
YoY Change -9.02%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.00K 161.0K 314.0K
YoY Change -86.96% -48.73% -69.22%
NET CHANGE
Cash From Operating Activities -3.129M -2.651M -2.284M
Cash From Investing Activities -169.0K -100.0K -114.0K
Cash From Financing Activities 21.00K 161.0K 314.0K
Net Change In Cash -3.277M -2.590M -2.084M
YoY Change 115.17% 24.28% 31.07%
FREE CASH FLOW
Cash From Operating Activities -$3.129M -$2.651M -$2.284M
Capital Expenditures $169.0K -$100.0K -$114.0K
Free Cash Flow -$3.298M -$2.551M -$2.170M
YoY Change 133.9% 17.56% -9.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000749660
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address State Or Province
EntityAddressStateOrProvince
NH
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-09341
dei Entity Registrant Name
EntityRegistrantName
iCAD, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
02-0377419
dei Entity Address Address Line1
EntityAddressAddressLine1
98 Spit Brook Road, Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashua
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
03062
dei City Area Code
CityAreaCode
603
dei Local Phone Number
LocalPhoneNumber
882-5200
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
ICAD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25446407
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24590000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34282000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
778000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
268000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8472000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8891000
CY2022Q3 us-gaap Inventory Net
InventoryNet
5630000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4171000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3787000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2962000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
42479000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
50306000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7275000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7106000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
986000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
882000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2945000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1059000
CY2022Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
67000
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
899000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8820000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8724000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
535000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
683000
CY2022Q3 us-gaap Goodwill
Goodwill
8362000
CY2021Q4 us-gaap Goodwill
Goodwill
8362000
CY2022Q3 us-gaap Assets
Assets
55374000
CY2021Q4 us-gaap Assets
Assets
62191000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2423000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2779000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5544000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5642000
CY2022Q3 icad Lease Liability Current
LeaseLiabilityCurrent
508000
CY2021Q4 icad Lease Liability Current
LeaseLiabilityCurrent
889000
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6126000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5652000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14601000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14962000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2480000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
266000
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
631000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
441000
CY2022Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
4000
CY2021Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
5000
CY2022Q3 us-gaap Liabilities
Liabilities
17716000
CY2021Q4 us-gaap Liabilities
Liabilities
15674000
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25428935
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25326086
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25243104
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25140255
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
254000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
253000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
302560000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
300859000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-263741000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253180000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
185831
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
185831
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1415000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1415000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
37658000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
46517000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55374000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62191000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6356000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9361000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21454000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25830000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1983000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2649000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6278000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7291000
CY2022Q3 us-gaap Gross Profit
GrossProfit
4373000
CY2021Q3 us-gaap Gross Profit
GrossProfit
6712000
us-gaap Gross Profit
GrossProfit
15176000
us-gaap Gross Profit
GrossProfit
18539000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2137000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2285000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6780000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6745000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3473000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3886000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10473000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10739000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2667000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2658000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8341000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7461000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
56000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
180000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
178000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
8333000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
8893000
us-gaap Operating Expenses
OperatingExpenses
25774000
us-gaap Operating Expenses
OperatingExpenses
25123000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3960000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2181000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10598000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
21000
us-gaap Investment Income Interest
InvestmentIncomeInterest
89000
us-gaap Investment Income Interest
InvestmentIncomeInterest
53000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-45000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6584000
CY2022Q3 us-gaap Interest Expense
InterestExpense
7000
CY2021Q3 us-gaap Interest Expense
InterestExpense
0
us-gaap Interest Expense
InterestExpense
7000
us-gaap Interest Expense
InterestExpense
141000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
71000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-386000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
62000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
37000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-515000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3898000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2176000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10561000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7099000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3898000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2176000
us-gaap Net Income Loss
NetIncomeLoss
-10561000
us-gaap Net Income Loss
NetIncomeLoss
-7099000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25204000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25204000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25053000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25053000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25183000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25183000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24662000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24662000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
40990000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
127000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
34000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
405000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3898000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
37658000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
46517000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
206000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
127000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1369000
us-gaap Net Income Loss
NetIncomeLoss
-10561000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
37658000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
51027000
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-59000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
297000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
76000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2176000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
49821000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
30525000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-59000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23229000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
933000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
190000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2102000
us-gaap Net Income Loss
NetIncomeLoss
-7099000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
49821000
us-gaap Profit Loss
ProfitLoss
-10561000
us-gaap Profit Loss
ProfitLoss
-7099000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
158000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
176000
us-gaap Depreciation
Depreciation
246000
us-gaap Depreciation
Depreciation
242000
icad Noncashlease Expense
NoncashleaseExpense
549000
icad Noncashlease Expense
NoncashleaseExpense
581000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
510000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-25000
us-gaap Share Based Compensation
ShareBasedCompensation
1369000
us-gaap Share Based Compensation
ShareBasedCompensation
2102000
icad Amortization Accretion Of Discounts And Premiums
AmortizationAccretionOfDiscountsAndPremiums
0
icad Amortization Accretion Of Discounts And Premiums
AmortizationAccretionOfDiscountsAndPremiums
17000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-386000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
91000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1827000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1459000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
146000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-493000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-351000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-217000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-98000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2095000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-602000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-514000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
663000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
65000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
901000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-762000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9660000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7861000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
10000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
355000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
426000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-365000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-450000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
206000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
933000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
127000
CY2022Q3 icad Contract With Customer Asset Non Current Net
ContractWithCustomerAssetNonCurrentNet
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
190000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23229000
icad Issuance Of Stock Upon Conversion Of Debentures
IssuanceOfStockUponConversionOfDebentures
0
icad Issuance Of Stock Upon Conversion Of Debentures
IssuanceOfStockUponConversionOfDebentures
7363000
icad Taxes Paid Related To Restricted Stock Program
TaxesPaidRelatedToRestrictedStockProgram
0
icad Taxes Paid Related To Restricted Stock Program
TaxesPaidRelatedToRestrictedStockProgram
59000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
333000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16930000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9692000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8619000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34282000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27186000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24590000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35805000
us-gaap Interest Paid Net
InterestPaidNet
7000
us-gaap Interest Paid Net
InterestPaidNet
92000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2434000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6356000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6356000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6356000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21454000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21454000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21454000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9361000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9361000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9361000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25830000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 2%;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risk and Uncertainty </div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March 12, 2020, the World Health Organization declared <div style="white-space:nowrap;display:inline;">COVID-19</div> to be a pandemic. In an effort to contain and mitigate the spread of <div style="white-space:nowrap;display:inline;">COVID-19,</div> the United States and most countries of the world imposed some level of unprecedented restrictions such as travel bans and business closures which caused substantial reductions in economic activity. As a provider of devices and services to the health care industry, the Company believes its operations have been materially affected in all periods presented. While the worst of the disruptions appear to have subsided as of September 30, 2022, the Company continues to be impacted by slowness in the overall economic recovery. The Company’s expected results for the year ended December 31, 2022, including any interim or future periods, could reflect a continuing negative impact from the <div style="white-space:nowrap;display:inline;">COVID-19</div> pandemic for similar or additional reasons. </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In late February 2022, Russian military forces launched significant military action against Ukraine. Sustained conflict and disruption in the region has continued through September 30, 2022 and beyond. Economic, civil, military and political uncertainty may arise or increase in regions where the Company operates or derives revenue. Further, countries from which the Company derives revenue may experience military action and/or civil and political unrest; may be subject to government export controls, economic sanctions, embargoes, or trade restrictions; and experience currency, inflation, and interest rate uncertainties. While the impact to the Company has been limited to date, it is not possible to predict the potential outcome should the conflict expand and/or additional sanctions be imposed. For the fiscal year ended 2021, approximately </div></div>8.6<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the Company’s total revenue and approximately </div>39.0<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the Company’s export revenue was derived from customers located in Europe.</div></div>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25830000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25830000
CY2022Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
8472000
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
8891000
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1584000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1895000
us-gaap Net Income Loss
NetIncomeLoss
-7099000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25204000
CY2021Q4 icad Contract With Customer Asset Non Current Net
ContractWithCustomerAssetNonCurrentNet
844000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6757000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6093000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6093000
icad Deferral Of Revenue
DeferralOfRevenue
9195000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-8531000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6757000
CY2022Q3 icad Deferredrevenuetoberecognizedinremainderoffiscalyearend
Deferredrevenuetoberecognizedinremainderoffiscalyearend
2300000
icad Deferred Revenue To Be Recognized In Next Twelve Months
DeferredRevenueToBeRecognizedInNextTwelveMonths
4200000
CY2022Q3 icad Deferred Revenue To Be Recognized Year Two
DeferredRevenueToBeRecognizedYearTwo
200000
CY2022Q3 icad Deferred Revenue To Be Recognized Year Four
DeferredRevenueToBeRecognizedYearFour
100000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3898000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2176000
us-gaap Net Income Loss
NetIncomeLoss
-10561000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25053000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25183000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24662000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
685000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
173000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2624154
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2511261
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
405000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
656000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1369000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2102000
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2300000
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2665000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2962000
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
121000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
173000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3113000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1279000
CY2022Q3 us-gaap Inventory Gross
InventoryGross
5899000
CY2021Q4 us-gaap Inventory Gross
InventoryGross
4414000
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
269000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
243000
CY2022Q3 us-gaap Inventory Net
InventoryNet
5630000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4171000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3652000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
664000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
icad Increase In Operating Lease Right Of Use Assets
IncreaseInOperatingLeaseRightOfUseAssets
2400000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
233000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
611000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
642000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
644000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
664000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y11M19D
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2988000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
508000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2480000
CY2021Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7354283000
CY2021Q1 us-gaap Partners Capital Account Units Sale Of Units
PartnersCapitalAccountUnitsSaleOfUnits
1393738
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
25100000
CY2021Q1 us-gaap Partners Capital Account Public Sale Of Units Net Of Offering Costs
PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts
23200000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2486511
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.27
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3820000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
760000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.22
icad Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalIntrinsicValue
3000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
73500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
85974000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
548857
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.96
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2642154
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.44
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1619855
CY2021Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.47
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3730000
CY2022Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1835848
CY2022Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
9.97
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2022Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
5800000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6356000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9361000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21454000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25830000
CY2022Q3 us-gaap Gross Profit
GrossProfit
4373000
CY2021Q3 us-gaap Gross Profit
GrossProfit
6712000
us-gaap Gross Profit
GrossProfit
15176000
us-gaap Gross Profit
GrossProfit
18539000
CY2022Q3 icad Segment Operating Income Loss
SegmentOperatingIncomeLoss
-1278000
CY2021Q3 icad Segment Operating Income Loss
SegmentOperatingIncomeLoss
498000
icad Segment Operating Income Loss
SegmentOperatingIncomeLoss
-2196000
icad Segment Operating Income Loss
SegmentOperatingIncomeLoss
929000
CY2022Q3 icad General Administrative Depreciation And Amortization Expense
GeneralAdministrativeDepreciationAndAmortizationExpense
2682000
CY2021Q3 icad General Administrative Depreciation And Amortization Expense
GeneralAdministrativeDepreciationAndAmortizationExpense
2679000
icad General Administrative Depreciation And Amortization Expense
GeneralAdministrativeDepreciationAndAmortizationExpense
8402000
icad General Administrative Depreciation And Amortization Expense
GeneralAdministrativeDepreciationAndAmortizationExpense
7513000
CY2022Q3 us-gaap Interest Expense
InterestExpense
7000
CY2021Q3 us-gaap Interest Expense
InterestExpense
0
us-gaap Interest Expense
InterestExpense
7000
us-gaap Interest Expense
InterestExpense
141000
CY2022Q3 icad Interest Income
InterestIncome
71000
CY2021Q3 icad Interest Income
InterestIncome
21000
icad Interest Income
InterestIncome
89000
icad Interest Income
InterestIncome
53000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-45000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-386000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3898000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2176000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10561000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7099000
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
3800000
CY2022Q3 icad Minimum Royalty Obligations
MinimumRoyaltyObligations
200000

Files In Submission

Name View Source Status
icad-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001193125-22-283502-index-headers.html Edgar Link pending
0001193125-22-283502-index.html Edgar Link pending
0001193125-22-283502.txt Edgar Link pending
0001193125-22-283502-xbrl.zip Edgar Link pending
d359646d10q.htm Edgar Link pending
d359646dex311.htm Edgar Link pending
d359646dex312.htm Edgar Link pending
d359646dex321.htm Edgar Link pending
d359646dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
icad-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
icad-20220930_def.xml Edgar Link unprocessable
icad-20220930_lab.xml Edgar Link unprocessable
icad-20220930_pre.xml Edgar Link unprocessable
d359646d10q_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending